covid pfizer - Search News

Order byBest matchMost fresh

FDA, COVID and Vaccine

Top News

Overview

Impacts

FDA expands COVID vaccine warning about possible side effect

The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis and pericarditis.

· 8h · on MSN

· 9h

InnovationRx: FDA Will Limit Covid-19 Vaccines To Those Over 65 Or At High Risk

· 9h · on MSN

FDA plans to limit COVID shots to those over 65 or with high-risk conditions

Covid Vaccine Boosters Won’t Be Available for Healthy Adults Under 65. How Will That Work?

Covid-19 vaccines will no longer be available to everyone. Instead, annual boosters will be limited to people ages 65 and older, and those with certain medical conditions that put them at high risk f...

· 5h

· 23h

FDA tightens requirements for COVID vaccine, adding trials for healthy adults

· 1d

Annual COVID-19 Shots For Healthy Younger Adults, Children Will No Longer Be Routinely Approved

FDA plans to limit COVID vaccine to only high-risk people. Who would still be eligible?

Public trust in vaccination has declined, potentially impacting other vital immunization programs.

· 9h

· 1d

New federal rules for COVID boosters could delay shots for healthy adults, kids

· 1d

FDA sets new COVID booster guidelines for healthy adults under 65

8hon MSN

US officials delayed warning public about heart inflammation risk from COVID shot: report

U.S. health officials knew about the risks of myocarditis from COVID-19 vaccines but downplayed the concern and delayed informing the public about the risks of taking the jab—that is according to a new Senate report released by GOP Sen.

Pfizer scientist claimed COVID vax results being delayed until after 2020 election ‘wasn’t a coincidence’: House GOP panel

The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr. Philip Dormitzer, may have “conspired to withhold public

1don MSN

FDA sets new COVID booster guidelines for healthy adults under 65

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

6don MSN

New Allegations About Timing of Pfizer Covid Vaccine Passed to House Panel

A former Pfizer scientist said the timing of the 2020 vaccine results “wasn’t a coincidence,” according to allegations provided by a rival drugmaker.

US House Panel Seeks Information From Pfizer Over Alleged COVID Vaccine Delay

WASHINGTON (Reuters) -U.S. lawmakers on Thursday asked Pfizer Inc for information on alleged comments by a former executive suggesting its research executives intentionally delayed clinical trial results of its COVID-19 vaccine to influence the 2020 presidential election.

6don MSN

House GOP requests records from Pfizer CEO and former executive in probe of Covid vaccine delay allegation

The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company executive to investigate an allegation that clinical testing related to the development of the company’s Covid-19 vaccine was purposefully delayed until after the 2020 presidential election.

AARP2d

Third COVID Vaccine Gets Approved for Adults 65 and Over

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) has officially approved a COVID-19 vaccine from Novavax for adults 65 and older and for individuals ages 12 to 64 who have an underlying health condition that puts them at higher risk for serious illness from a coronavirus infection.

Pfizer: Better To Face The Harsh Reality Than Continue Waiting

Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click to find out why PFE stock is a Hold.